Healthcare Jan 17, 2022 10:09 AM (GMT+8) · EqualOcean
Yiouda health on January 17, recently, Jialiang medical announced that it had completed hundreds of millions of yuan of round B financing, which was led by Qiming venture capital, followed by Yuanjing capital and CICC Chuanyu Phoenix fund under CICC capital, the former shareholder Chende capital continued to hold, and Dianshi capital acted as the exclusive financial adviser. The funds raised will be used to further expand the R & D pipeline, clinical trials, personnel supplement, etc. Founded in 2020, Jialiang medical is a high-tech group company focusing on neurosurgery and brain science research. It owns the brands of Novartis medical and Newton technology. Through years of research and development, innovative medical device solutions such as drug refractory epilepsy, brain tumor, Parkinson's disease and depression have been arranged to become a trusted solution leader in the field of Neuromedicine in the world. Jialiang medical also provides brain computer interface research services and overall solutions based on neurocognition and diseases, including optogenetic research equipment and consumables. Epilcure, a neuroelectric stimulator for refractory epilepsy, was jointly developed and produced by Nuowei medical and Zhejiang University. Epilcure has completed the first clinical implantation in Asia in March 2021.